These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21344501)

  • 1. Predictors of 12-week remission in a nationwide cohort of people with depressive disorders: the CRESCEND study.
    Kim JM; Kim SW; Stewart R; Kim SY; Yoon JS; Jung SW; Lee MS; Yim HW; Jun TY
    Hum Psychopharmacol; 2011 Jan; 26(1):41-50. PubMed ID: 21344501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early response and remission as predictors of a good outcome of a major depressive episode at 12-month follow-up: a prospective, longitudinal, observational study.
    Ciudad A; Álvarez E; Roca M; Baca E; Caballero L; García de Polavieja P; Casillas M; Valladares A; Gilaberte I
    J Clin Psychiatry; 2012 Feb; 73(2):185-91. PubMed ID: 22053897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.
    Yevtushenko VY; Belous AI; Yevtushenko YG; Gusinin SE; Buzik OJ; Agibalova TV
    Clin Ther; 2007 Nov; 29(11):2319-32. PubMed ID: 18158074
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gender differences in 12-week antidepressant treatment outcomes for a naturalistic secondary care cohort: the CRESCEND study.
    Yang SJ; Kim SY; Stewart R; Kim JM; Shin IS; Jung SW; Lee MS; Jeong SH; Jun TY
    Psychiatry Res; 2011 Aug; 189(1):82-90. PubMed ID: 21216471
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical milestones predict symptom remission over 6-month and choice of treatment of patients with major depressive disorder (MDD).
    Wade AG; Schlaepfer TE; Andersen HF; Kilts CD
    J Psychiatr Res; 2009 Feb; 43(5):568-75. PubMed ID: 18954875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Residual symptoms after a treated major depressive disorder: in practice ambulatory observatory carried out of city].
    Mouchabac S; Ferreri M; Cabanac F; Bitton M
    Encephale; 2003; 29(5):438-44. PubMed ID: 14615693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive socioeconomic and clinical profiles of antidepressant response and remission.
    Jain FA; Hunter AM; Brooks JO; Leuchter AF
    Depress Anxiety; 2013 Jul; 30(7):624-30. PubMed ID: 23288666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of fluoxetine remission for hospitalized patients with major depressive disorder.
    Lin CH; Lane HY; Chen CC; Juo SH; Yen CF
    Psychiatry Clin Neurosci; 2011 Aug; 65(5):510-7. PubMed ID: 21851460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Association between health related quality of life and severity of depression in patients with major depressive disorder].
    Cao Y; Li W; Shen J; Zhang Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Feb; 36(2):143-8. PubMed ID: 21368424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Concurrent anxiety and substance use disorders among outpatients with major depression: clinical features and effect on treatment outcome.
    Howland RH; Rush AJ; Wisniewski SR; Trivedi MH; Warden D; Fava M; Davis LL; Balasubramani GK; McGrath PJ; Berman SR
    Drug Alcohol Depend; 2009 Jan; 99(1-3):248-60. PubMed ID: 18986774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and drug induced side effects in early versus late antidepressant responders.
    Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
    J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is prior course of illness relevant to acute or longer-term outcomes in depressed out-patients? A STAR*D report.
    Rush AJ; Wisniewski SR; Zisook S; Fava M; Sung SC; Haley CL; Chan HN; Gilmer WS; Warden D; Nierenberg AA; Balasubramani GK; Gaynes BN; Trivedi MH; Hollon SD
    Psychol Med; 2012 Jun; 42(6):1131-49. PubMed ID: 22008447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of antidepressant medication treatment on suicidal ideation and behavior in a randomized trial: an exploratory report from the Combining Medications to Enhance Depression Outcomes Study.
    Zisook S; Lesser IM; Lebowitz B; Rush AJ; Kallenberg G; Wisniewski SR; Nierenberg AA; Fava M; Luther JF; Morris DW; Trivedi MH
    J Clin Psychiatry; 2011 Oct; 72(10):1322-32. PubMed ID: 22075098
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moderate exercise improves depression parameters in treatment-resistant patients with major depressive disorder.
    Mota-Pereira J; Silverio J; Carvalho S; Ribeiro JC; Fonte D; Ramos J
    J Psychiatr Res; 2011 Aug; 45(8):1005-11. PubMed ID: 21377690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid improvement of depression and quality of life with escitalopram treatment in outpatients with breast cancer: a 12-week, open-label prospective trial.
    Park HY; Lee BJ; Kim JH; Bae JN; Hahm BJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):318-23. PubMed ID: 22142651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of childhood adversity on the course and suicidality of depressive disorders: the CRESCEND study.
    Kim SW; Kang HJ; Kim SY; Kim JM; Yoon JS; Jung SW; Lee MS; Yim HW; Jun TY
    Depress Anxiety; 2013 Oct; 30(10):965-74. PubMed ID: 23495050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing remission in major depressive disorder and generalized anxiety disorder clinical trials with the discan metric of the Sheehan disability scale.
    Sheehan DV; Harnett-Sheehan K; Spann ME; Thompson HF; Prakash A
    Int Clin Psychopharmacol; 2011 Mar; 26(2):75-83. PubMed ID: 21102344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between a history of a suicide attempt and treatment outcomes in patients with depression.
    Kim SW; Stewart R; Kim JM; Shin IS; Yoon JS; Jung SW; Lee MS; Yim HW; Jun TY
    J Clin Psychopharmacol; 2011 Aug; 31(4):449-56. PubMed ID: 21694625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of a quantitative electroencephalographic biomarker for predicting differential response or remission with escitalopram and bupropion in major depressive disorder.
    Leuchter AF; Cook IA; Gilmer WS; Marangell LB; Burgoyne KS; Howland RH; Trivedi MH; Zisook S; Jain R; Fava M; Iosifescu D; Greenwald S
    Psychiatry Res; 2009 Sep; 169(2):132-8. PubMed ID: 19709754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.